BSIM Therapeutics obtains NP 4457 certification in Research, Development and Innovation (RDI) Management
20 September, 2019
BSIM Therapeutics’ Research, Development and Innovation (RDI) system has been certified through the NP 4457:2007 standard. This Portuguese standard defines the requirements of an effective RDI system, with the major goal of helping organizations to define their RDI policy and to achieve their innovation goals. This certification covers all BSIM Therapeutics’ activities relating to “Research, Development and Innovation of novel therapeutic drugs for the treatment of neurodegenerative diseases”.